Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.
作者信息
Bonnet R
机构信息
Laboratoire de Bactériologie, Faculté de Médecine, 63001 Clermont-Ferrand Cedex, France.
出版信息
Antimicrob Agents Chemother. 2004 Jan;48(1):1-14. doi: 10.1128/AAC.48.1.1-14.2004.
Abstract
摘要
相似文献
1
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.
Antimicrob Agents Chemother. 2004 Jan;48(1):1-14. doi: 10.1128/AAC.48.1.1-14.2004.
2
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Can J Microbiol. 2004 Mar;50(3):137-65. doi: 10.1139/w03-111.
3
CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.
Int J Antimicrob Agents. 2000 Mar;14(2):137-42. doi: 10.1016/s0924-8579(99)00165-x.
4
First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Antimicrob Agents Chemother. 2007 Nov;51(11):4015-21. doi: 10.1128/AAC.00576-07. Epub 2007 Aug 27.
5
Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea.
Antimicrob Agents Chemother. 2005 Apr;49(4):1572-5. doi: 10.1128/AAC.49.4.1572-1575.2005.
6
7
CTX-M: changing the face of ESBLs in the UK.
J Antimicrob Chemother. 2005 Sep;56(3):451-4. doi: 10.1093/jac/dki239. Epub 2005 Jul 8.
8
Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability.
J Mol Biol. 2005 Apr 29;348(2):349-62. doi: 10.1016/j.jmb.2005.02.010.
9
Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases.
Antimicrob Agents Chemother. 2015 Nov;59(11):6741-8. doi: 10.1128/AAC.00618-15. Epub 2015 Aug 17.
10
Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
J Clin Microbiol. 2004 Dec;42(12):5715-21. doi: 10.1128/JCM.42.12.5715-5721.2004.
引用本文的文献
1
Antibacterial Potential of Nanocrystalline Zinc-Cobalt Ferrite.
Nanomaterials (Basel). 2025 Aug 28;15(17):1318. doi: 10.3390/nano15171318.
2
Fluorinated Rh(I)-NHC Compounds as Potential Antibacterials Against Multidrug-Resistant Clinical Isolates Producing ESBL.
Pharmaceutics. 2025 Jul 28;17(8):973. doi: 10.3390/pharmaceutics17080973.
3
Low prevalence but high resistance of Extended Spectrum Beta-lactamase producing isolated from Hospitals in the Ashanti Region of Ghana.
Afr Health Sci. 2025 Jun;25(2):20-29. doi: 10.4314/ahs.v25i2.4.
4
Analyzing in Wuhan: Serotypes, Antimicrobial Resistance, and Public Health Implications.
Infect Drug Resist. 2025 Jul 28;18:3745-3760. doi: 10.2147/IDR.S522808. eCollection 2025.
5
Antibiotic Resistance, Virulence Genes, and Molecular Diversity of Clinical Isolates from Patients of District Hospital in Central Poland.
Pathogens. 2025 Jun 30;14(7):648. doi: 10.3390/pathogens14070648.
6
Antibiotic Resistance and Molecular Epidemiology of ESBL-Producing E. coli in Shrimp Aquaculture: A Study from Tiruvallur District, Tamil Nadu, India.
Curr Microbiol. 2025 Jul 22;82(9):401. doi: 10.1007/s00284-025-04329-4.
7
Probing the modulation of enzyme kinetics by multi-temperature, time-resolved serial crystallography.
Nat Commun. 2025 Jul 16;16(1):6553. doi: 10.1038/s41467-025-61631-2.
8
Antimicrobial resistance and beta-lactamase gene distribution among clinical isolates: a two-year cohort study.
Sci Rep. 2025 Jul 4;15(1):23951. doi: 10.1038/s41598-025-08445-w.
9
Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit.
Biomedicines. 2025 May 29;13(6):1333. doi: 10.3390/biomedicines13061333.
10
Ceftriaxone-resistant Panama ST48 detected in poultry food chain: A phylogeographical analysis.
One Health. 2025 May 12;20:101073. doi: 10.1016/j.onehlt.2025.101073. eCollection 2025 Jun.
本文引用的文献
1
Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States.
Antimicrob Agents Chemother. 2003 Jul;47(7):2382-3. doi: 10.1128/AAC.47.7.2382-2383.2003.
2
Effect of D240G substitution in a novel ESBL CTX-M-27.
J Antimicrob Chemother. 2003 Jul;52(1):29-35. doi: 10.1093/jac/dkg256. Epub 2003 May 29.
3
Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens.
Antimicrob Agents Chemother. 2003 Jun;47(6):2056-8. doi: 10.1128/AAC.47.6.2056-2058.2003.
4
Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan.
J Antimicrob Chemother. 2003 Mar;51(3):631-8. doi: 10.1093/jac/dkg103.
5
CTX-M extended-spectrum beta-lactamase arrives in the UK.
J Antimicrob Chemother. 2003 Feb;51(2):470-1. doi: 10.1093/jac/dkg096.
6
Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.
Antimicrob Agents Chemother. 2003 Feb;47(2):790-3. doi: 10.1128/AAC.47.2.790-793.2003.
7
In34, a complex In5 family class 1 integron containing orf513 and dfrA10.
Antimicrob Agents Chemother. 2003 Jan;47(1):342-9. doi: 10.1128/AAC.47.1.342-349.2003.
8
An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.
J Antimicrob Chemother. 2003 Jan;51(1):195-6. doi: 10.1093/jac/dkg051.
9
Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.
J Antimicrob Chemother. 2002 Dec;50(6):1031-4. doi: 10.1093/jac/dkf240.
10
Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China.
Diagn Microbiol Infect Dis. 2002 Oct;44(2):195-200. doi: 10.1016/s0732-8893(02)00441-8.
Zotero 插件